Next Article in Journal
Incidence and Associated Factors of SARS-CoV-2 Infection Post-mRNA-1273 Booster Vaccination in Health-Care Workers
Previous Article in Journal
Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
Previous Article in Special Issue
Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas
 
 
vaccines-logo
Article Menu
Article

Article Versions Notes

Vaccines 2023, 11(2), 480; https://doi.org/10.3390/vaccines11020480
Action Date Notes Link
article html file updated 4 September 2025 21:13 CEST Update https://www.mdpi.com/2076-393X/11/2/480/html
article html file updated 9 March 2023 21:05 CET Update -
article html file updated 24 February 2023 07:59 CET Update -
article pdf uploaded. 24 February 2023 07:58 CET Updated version of record https://www.mdpi.com/2076-393X/11/2/480/pdf
article xml uploaded. 24 February 2023 07:58 CET Update https://www.mdpi.com/2076-393X/11/2/480/xml
article xml file uploaded 24 February 2023 07:58 CET Update -
article html file updated 20 February 2023 09:44 CET Update -
article pdf uploaded. 20 February 2023 09:43 CET Updated version of record https://www.mdpi.com/2076-393X/11/2/480/pdf-vor
article xml uploaded. 20 February 2023 09:43 CET Update -
article xml file uploaded 20 February 2023 09:43 CET Update -
article html file updated 20 February 2023 07:58 CET Original file -
article pdf uploaded. 20 February 2023 07:57 CET Updated version of record https://www.mdpi.com/2076-393X/11/2/480/pdf-vor
article xml uploaded. 20 February 2023 07:57 CET Update -
article xml file uploaded 20 February 2023 07:57 CET Original file -
article supplementary file uploaded. 18 February 2023 14:05 CET - https://www.mdpi.com/2076-393X/11/2/480#supplementary
article pdf uploaded. 18 February 2023 14:05 CET Version of Record https://www.mdpi.com/2076-393X/11/2/480/pdf-vor
Back to TopTop